Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Solid Tumor, Adult, Colorectal Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer, CRC, NSCLC, Pancreas Cancer, Mesothelioma, Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Mesothelioma, Malignant, Mesothelioma; Lung, Cancer, CAR T Cell Therapy, Next Generation Sequencing, Leukapheresis, Apheresis, Immunotherapy, Pancreatic Neoplasms, Malignant Mesothelioma, Next Generation Sequencing (NGS), Long Range NGS HLA typing
Lead Scientist at UCLA
- J. Randolph Hecht, MD
Dr. Joel R. Hecht holds the Carol and Saul Rosenzweig Endowed Chair for Cancer Therapies Development.